We recently compiled a list of the 14 Worst 52-Week High Stocks to Buy According to Short Sellers. In this article, we are ...

Fintel reports that on September 20, 2024, Jefferies upgraded their outlook for Assembly Biosciences (NasdaqGS:ASMB) from ...

IGM Biosciences has collaboration deal with Sanofi inked in 2022 and its stock has almost doubled in 2024 year to date. Read ...

Parse raised $50 million in December. The company had more than 100 employees at the time, with about 70% of them based in ...

MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of peptide therapies for the treatment of endocrine and metabolic disorders. Its ...

The company would raise $136 million at the top of that range. MBX has applied to be listed on Nasdaq under the ticker “MBX.” ...

Phase 3 Study to Assess PF614 Efficacy in Treating Post-Surgical Pain SAN DIEGO, CA / ACCESSWIRE / September 19, 2024 / ...

According to a Schedule 13D filed on September 19, 2024 with the U.S. Securities and Exchange Commission (the “SEC”) disclosing Concentra’s proposal, Tang Capital is the controlling stockholder of ...

Xenetic Biosciences, Inc. (NASDAQ:XBIO) (”Xenetic” or the “Company”), a biopharmaceutical company focused on advancing ...

Genknowme, a start-up specializing in epigenetics research, has integrated multichannel pipettes from INTEGRA Biosciences ...

IGM Biosciences Inc’s IGMS share price has surged by 28.78%, which has investors questioning if this is right time to sell.

BF Biosciences Limited is looking to raise Rs. 1.38 billion to Rs. 1.93 billion by issuing 28.3 percent new shares through an ...